Viral Genetics Inc. Appoints Dr. Baruch S. Blumberg to its Advisory Board

SAN MARINO, Calif.--(BUSINESS WIRE)--Nobel Laureate Dr. Baruch S. Blumberg, MD, PhD., has joined the advisory board of Viral Genetics, Inc., (OTC:VRAL.PK) headquartered in San Marino, California. Dr. Blumberg won the 1976 Nobel Prize in Medicine for the discovery of the Hepatitis-B virus. He is the second Nobel Laureate to join the advisory board of Viral Genetics, a biotechnology company pursing drug compounds for people with autoimmune diseases including HIV/AIDS and Lyme Disease, as well as investigating treatments for staph, strep and drug resistant cancer cells. Dr. Blumberg developed the diagnostic test for the detection of the Hepatitis-B virus and the first retroviral vaccine for protection from its dreaded consequences. He is credited with saving many millions of lives.
MORE ON THIS TOPIC